Background Image

HEPUDRAIN [Specialities]

HEPUDRAIN is a dietary supplement that provides, by means of the six active ingredients in a fully natural way for an efficient detoxification of the liver.
natural energy HEPUDRAIN
Prijs : € 60 capsules
(CNK: 3255-320) at your pharmacist
Contact
HEPUDRAIN

Nowadays, our body is constantly inundated by toxins, mainly originating from our daily food (pesticides, preservatives, artificial flavors, fragrances and dyes), but also from medication and environmental pollution.

Therefore our body needs to detoxify permanently from these toxins. Detoxification occurs mainly in the liver. In case of a high toxic load and/or a liver disorder, an overload of the liver may concur resulting in a insufficient detoxifying effect of the liver. Often, this leads to a reduced quality of life with momentary complaints such as fatigue, headache, abdominal discomfort, constipation, nausea, a metallic taste, skin complaints and itching.

HEPUDRAIN contains as active ingredients milk thistle,artichoke, boldo, choline, turmeric and N-acetyl-cysteine. The synergistic effect of these six active ingredients ensures an detoxification effect acting at phase 1 and phase 2 of the detoxification of the liver.
 
 

Extra

Instruction for use
 2 capsules per day with the main meal. 

Do not exceed the recommended daily dose.
 
Keep out of reach of young children.
 
Nutritional supplements should not replace a varied and balanced diet and a healthy lifestyle.

Do not administer to children under the age of 12, pregnant women and women who feed bread.

Consult your doctor or pharmacist with concomitant use of anticoagulants.

This product is not suitable for people with biliary obstruction.

Avoid overdose in case of a stomach ulcer. (Overconsumption can stimulate the stomach lining.

Check with simultaneous intake of medicines.
 
No long-term use without professional advice.

PL_AS 1429/29



 

Range of usage

• Detoxification of the liver.
 

Composition
Ingredients per 2 vegetable capsules
Anti-caking agents (Magnesium silicate, Magnesium stearate, Silicon dioxide), Choline bitartrate 250mg, Vegetable capsule (Hypromellose), Cynara scolymus L. (Artichoke) dry extract 200mg, Peumus boldus Molina (Boldo) dry extract 200mg, Silybum marianum (L.) Gaertn. (Milk thistle) dry extract200mg, Curcuma longa L. (Turmeric) dry extract 150mg, N-acetyl-L-cysteine ​​100mg
References
1] Zhou, M., A.G. Engel, and A. Auerbach. 1999. Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes. Proc. Natl. Acad. Sci. USA. 96:10466–10471

[1] Lombardi B, Pani P, Schlunk FF. Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res. (1968)

[1] Bruni C, Hegsted DM. Effects of choline-deficient diets on the rat hepatocyte. Electron microscopic observations. Am J Pathol. (1970)

[1] Guarner, F. 2005. Inulin and oligofructose: impact on intestinal diseases and disorders. Br. J. Nutr. 93(Suppl.):61S-­‐65S. 2

[1]Kraft K. Artichoke leaf extract — recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts.Phytomedicine 1997;4:369-­‐78.

[1] Fintelmann V. Therapeutic profile and mechanisms of action of artichoke leaf extract: hypolipemic, antioxidant, hepatoprotective and choleretic properties. Phytomedicine 1996;(11 Suppl):50.

[1] Pittler MH, Ernst E. Artichoke leaf extract for serum cholesterol reduction. Perfusion 1998;11:338-­‐40.

[1] Fintelmann V. Antidyspeptic and lipid-­‐lowering effect of artichoke leaf extract. Z Allg Med++1996;72(Suppl 2):48-­‐57

[1] Englisch W, et al. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung. (2000)

[1] Fintelmann V. Artischockenextrakt bei dyspeptischem Symptomenkomplex. Methodik und Ergebnisse einer Anwendungsbeobachtung. Z Phytother 1999; 20:93-­‐5.

[1] Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol. 2010;48:803–806.

[1] Deak G, Muzes G, Lang I, Niederland V, Nekam K, Gonzalez-­‐Cabello R, Gergely P, Feher J. Immunomodula-­‐ tor effect of silymarin therapy in chronic alcoholic liver diseases. Orv Hetil. 1990;131:1291–1292. 1295– 1296

[1] Kim M, Yang S-G, Kim JM, Lee J-W, Kim YS, Lee JI. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med. 2012;30:473–479.

[1] Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y, Sloan DD, et al. Silymarin Inhibits in Vitro T Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection. Gastroenterology. 2009

[1] Katiyar SK. Silymarin and skin cancer prevention: anti-­‐inflammatory, antioxidant and immunomodulatory effects. Int JOncol. 2005; 26:169 –176

[1] Salamone F, et al. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res. (2012)

[1] Hahn,G., Lehmann,H.D., Kurten,M., Ubel,H. and Vogel,G. (1968) Zur Pharmakologie und Toxikologie von Silymarin, des antihepatotoxischen Wirkprinzipes aus Silybum marianum (L.) Gaertn. Arzneim.-­‐Forsch., 18, 698–704.

[1] Fiebrich,F. and Koch,H. (1979) Silymarin, an inhibitor of prostaglandin synthetase. Experientia, 35, 1550–1552.

[1] Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther. 2007;6:110–119.

[1] Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized silymarin. Gastroenterology. 2007; 132: 1925 –1936

[1] Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology. 2007 May; 132(5):1925-­‐ 36.

[1] Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase‐2, prostaglandin E2 and prostaglandin E2 receptors.Carcinogenesis. 2011;32:86–92.

[1] Huseini HF, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20:1036–1039.

[1] Drugs R D. 2005;6(6):395-­‐400. Influence of silymarin administration on hepatic glutathione-conjugating
enzyme system in rats treated with antitubercular drugs.Victorrajmohan C, Pradeep K, Karthikeyan S.

[1] Sayyah M, Boostani H, Pakseresht S et al. Comparison of Silybum marianum (L.) gaertn. with fluoxetine in the treatment of obsessive-­‐compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry.2010;34(2):362-­‐5.

[1] Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migra-tion by reducing the expressions of cyclooxygenase-­‐2, prostaglandin E2 and prostaglandin E2 receptors.Carcinogenesis. 2011;32:86–92.

[1] Bruneton J. Pharmacognosie : Phytochimie, Plantes Médicinales. 3ème éd. Paris: Tec & Doc, EM inter.; 1999. (Fre). 1120p

[1] Middleton M J R, Chithan K, Theoharis C T. The effects of plant flavonoids on mammalian cells : Implications for inflammation, heart disease and cancer. Pharmacol Rev. 2000;52:673–751

[1] Wang YJ, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. (1997)

[1] Cheng AL, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. (2001)

[1] Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. (2011)

[1] Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. (1999)

[1] Giannessi F, et al. Curcumin protects Leydig cells of mice from damage induced by chronic alcohol administration. Med Sci Monit. (2008)

[1] Quintans LN, Castro GD, Castro JA. Oxidation of ethanol to acetaldehyde and free radicals by rat testicular microsomes. Arch Toxicol. (2005)

[1] Chandra AK, et al. Effect of curcumin on chromium-induced oxidative damage in male reproductive system. Environ Toxicol Pharmacol. (2007)

[1] Aktas C, et al. Anti-apoptotic effects of curcumin on cadmium-induced apoptosis in rat testes. Toxicol Ind Health. (2012)

[1] Um MY, et al. Curcumin Attenuates Diet-Induced Hepatic Steatosis by Activating AMPK. Basic Clin Pharmacol Toxicol. (2013)

[1] Bergeron R, Russell RR, Young LH, Ren JM, Marcucci M, Lee A, Shulman GI (May 1999). "Effect of AMPK activation on muscle glucose metabolism in conscious rats". Am. J. Physiol. 276 (5 Pt 1): E938–44.

[1] Witschi A, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. (1992)

[1] Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem. (2003)

[1] Giordano G, White CC, Costa LG. Assessment of glutathione homeostasis. Methods Mol Biol. (2011)

[1] Bates C.J, Manssor M.A, Gregory J, Pentieva K, Prentice A. Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of Young People Aged 4–18 years, and a comparison with the Survey of People Aged 65 Years and Over. Br. J. Nutr. 2002;87:71–79. 10.1079/BJN2001479

[1] Karbasi A, et al. Effect of oral N-acetyl cysteine on eradication of Helicobacter pylori in patients with dyspepsia. Minerva Gastroenterol Dietol. (2013)

[1] Scalley RD, Conner CS. Acetaminophen poisoning: a case report of the use of acetylcysteine. Am J Hosp Pharm. (1978)

[1] Wang L, Wang Z, Liu J. Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats. Hum Exp Toxicol. (2010)

[1] Wang AL1, et al. A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice. Hepatol Res. (2006)

[1] Ferreira Seiva FR1, et al. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats. Alcohol. (2009)

[1] Davis-­‐Searles PR, Nakanishi Y, Kim NC, Graf TN, Oberlies NH, Wani MC, Wall ME, Agarwal R, Kroll DJ. (2005) Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res 65:4448–4457
 
 
Background Image

Nature is our science.

natural energy Specialiteiten
Vegetable and bioidentical

The efficiency of all Natural Energy products is to be found in the way in which the active ingredients are adapted to be absorbed by the body as efficiently as possible.
Read more >>

natural energy Specialiteiten
Quality

Quality is essential to launch a safe and good product on the market. A good product contains active ingredients in a forms available to the human body so that these ingredients show positive health effects when used correctly.
Read more >>

natural energy Specialiteiten
Scientic research

In our laboratories these ingredients are optimized in innovative ways in order to obtain supplements that are distinguished by their exceptional efficiency and maximum safety.
Read more >>

Scientific hotline.

A question? Don't hesitate contact our experts.

Ask your question